Kamran Ahmed
Moffitt Cancer Center · King's College London · H. Lee Moffitt Cancer Center and Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kamran Ahmed as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:29 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07357298 · Phase III Trial of Brain MRI Surveillance in Stage IV Breast CancerH. Lee Moffitt Cancer Center and Research Institute · recruiting · Breast Cancer · principal investigator
- Ph2NCT06833502 · Phase II Study of Systemic Screening in Pathologic Node Positive Breast CancerH. Lee Moffitt Cancer Center and Research Institute · recruiting · Breast Cancer, Node-positive Breast Cancer · principal investigator
- Ph1/Ph2NCT06238921 · Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain MetastasesH. Lee Moffitt Cancer Center and Research Institute · recruiting · Breast Cancer, Triple Negative Breast Cancer · principal investigator
- Ph2NCT05528133 · Genomically Guided Radiation Therapy in the Management of Triple Negative Breast CancerH. Lee Moffitt Cancer Center and Research Institute · recruiting · Triple Negative Breast Cancer · principal investigator
- N/ANCT04647474 · Mental Wellbeing and Quality of Life in Prostate CancerKing's College London · completed · Prostate Cancer · principal investigator
- Ph1/Ph2NCT04588545 · Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal DiseaseH. Lee Moffitt Cancer Center and Research Institute · active not recruiting · HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease · principal investigator
- Ph1NCT03807765 · Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain MetastasesH. Lee Moffitt Cancer Center and Research Institute · completed · Metastatic Breast Cancer, Brain Metastases · principal investigator
- Ph2NCT03614949 · SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical CancerH. Lee Moffitt Cancer Center and Research Institute · active not recruiting · Cervical Cancer, Cervical Cancer Recurrent, Cervical Cancer Metastatic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:29 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients.Eur J Clin Pharmacol · 201229 citationsRCR 1.2
- Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study.J Immunother Cancer · 202510 citationsRCR 1.9
- 9 citationsRCR 0.9
- 8 citationsRCR 2.5
- Phase 2 Study of Preoperative SABR for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiation Therapy.Int J Radiat Oncol Biol Phys · 20236 citationsRCR 0.6
- Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial.Ann Surg Oncol · 20251 citationsRCR 0.5